Related Experiment Video
Updated: Jul 21, 2026
07:01
An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma
Published on: April 17, 2013
21.0K
Thyroid metastases from cervical carcinoma: unusual implications for clinicians-case report
Qian Yang1, Weipeng Yan1, Ning Wang1
1Department of Radiology, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
BMC Endocrine Disorders
|December 20, 2024
Summary
Thyroid metastases from uterine cervical cancer are rare but serious. Early diagnosis via imaging and pathology is key, as surgical intervention may offer some survival benefit.
Area of Science:
- Oncology
- Endocrinology
- Pathology
Background:
- Thyroid metastases from uterine cervical carcinoma are exceptionally rare.
- Distinguishing thyroid metastases from primary thyroid cancer is crucial for accurate diagnosis and treatment planning.
Observation:
- Presents two cases of uterine cervical cancer metastasizing to the thyroid gland.
- Analyzes imaging, pathological features, diagnosis, prognosis, and treatment through literature review.
- Highlights the importance of imaging as an auxiliary tool and pathology as the gold standard due to lack of specific laboratory indicators.
Findings:
- Thyroid malignancies are predominantly primary tumors, but metastases should be considered in patients with a history of cancer.
- Metastases to the thyroid, though uncommon, can occur in advanced stages of cervical cancer.
- Thyroid metastases from cervical carcinoma are associated with poor outcomes.
Implications:
- Surgical excision of metastatic thyroid cancer can alleviate compression symptoms and potentially prolong survival.
- Further research is essential to enhance clinical outcomes for this rare condition.
- Emphasizes the need for a high index of suspicion for thyroid metastases in relevant patient populations.
Related Concept Videos
01:25Hyperthyroidism I: Introduction
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
01:27Hyperthyroidism II: Pathophysiology
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
01:28Graves' Disease I: Introduction
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
01:24Graves Disease II: Pathophysiology
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...